Skip to main content
Fig. 14 | Theoretical Biology and Medical Modelling

Fig. 14

From: Analysis of the role of thrombomodulin in all-trans retinoic acid treatment of coagulation disorders in cancer patients

Fig. 14

Thrombin generation profile on days 1, 8 and 15 of treatment period with a daily dose of 110 \( \frac{mg}{m^2} \) RA. Dashed lines show the maximum impact of RA therapy on thrombin generation on different treatment days. The area between each dashed line and the solid blue line indicates the range of the thrombin generation profile on different treatment days. RA concentration in plasma on different treatment days is shown in Fig. 10

Back to article page